v3.26.1
Segment Reporting
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 17 – SEGMENT REPORTING

 

As of December 31, 2025, the Company had three reportable segments: Health Services, Digital Healthcare, and Medical Distribution. The Health Services division is comprised of the operations of (i) NCFM, a functional medical practice engaged in improving the health of its patients through individualized and integrative health care, (ii) BTG, a physical therapy practice in Bonita Springs, Florida that provides hands-on functional manual therapy techniques to speed patients’ recovery and manage pain without pain medication or surgery (sold in October 2025), (iii) CCN, a primary care providing a comprehensive range of medical services, and (iv) AEU, a minimally and non-invasive cosmetic services. During 2024, the Company replaced its NWC Obstetrics and Gynecology (OB/GYN) practice with CCN and relocated its AEU practice to the CCN office location. During May 2025, the Company consolidated the NCFM, AEU and CCN practices into the former NWC office. During October 2025, the Company sold the assets associated with its BTG practice.

 

The Digital Healthcare segment develops and plans to operate an online personal medical information and record archive system, the “HealthLynked Network,” which facilitates efficient management of medical records and care, allowing seamless patient appointment scheduling, comprehensive telemedicine services, and a cloud-based system for medical information and records management.

 

The Medical Distribution Division is comprised of the operations of MOD, a virtual distributor of discounted medical supplies selling to both consumers and medical practices throughout the United States.

 

The Company evaluates performance and allocates resources based on profit or loss from operations before income taxes. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies.

Segment information for the year ended December 31, 2025 was as follows:

 

   Year Ended December 31, 2025 
   Health Services   Digital Healthcare   Medical Distribution   Total 
Revenue                
Patient service revenue, net  $2,002,548   $
–
   $
–
   $2,002,548 
Subscription revenue   
–
    22,623    
–
    22,623 
Product and other revenue   
–
    
–
    40,121    40,121 
Total revenue   2,002,548    22,623    40,121    2,065,292 
                     
Operating Expenses                    
Practice salaries and benefits   1,016,543    
–
    
–
    1,016,543 
Other practice operating expenses   973,048    
–
    
–
    973,048 
Cost of product revenue   
–
    
–
    51,568    51,568 
Selling, general and administrative expenses   
–
    2,007,845    27,671    2,035,516 
Depreciation and amortization   97,175    4,696    
–
    101,871 
Total Operating Expenses   2,086,766    2,012,541    79,239    4,178,546 
                     
Income (loss) from operations  $(84,218)  $(1,989,918)  $(39,118)  $(2,113,254)
                     
Other Segment Information                    
Gain on extinguishment of debt  $
–
   $(317,982)  $
–
   $(317,982)
Loss on change in fair value of debt  $
–
   $618,208   $
–
   $618,208 
Gain on sale of assets  $
–
   $(168,722)  $
–
   $(168,722)
Gain on change in fair value of derivative financial instruments  $
–
   $(8,644)  $
–
   $(8,644)
Amortization of original issue discounts on notes payable  $12,022   $815,984   $
–
   $828,006 
Interest expense and other  $3,051   $213,083   $
–
   $216,134 
                     
Identifiable Assets                    
Identifiable assets as of December 31, 2025  $182,146   $1,519,025   $1,175   $1,702,346 

Segment information for the year ended December 31, 2024 was as follows:

 

   Year Ended December 31, 2024 
   Health Services   Digital Healthcare   Medical Distribution   Total 
Revenue                
Patient service revenue, net  $2,872,177   $
–
   $
–
   $2,872,177 
Subscription revenue   
–
    32,425    
–
    32,425 
Product and other revenue   
–
    
–
    103,759    103,759 
Total revenue   2,872,177    32,425    103,759    3,008,361 
                     
Operating Expenses                    
Practice salaries and benefits   1,995,127    
–
    
–
    1,995,127 
Other practice operating expenses   1,556,759    
–
    
–
    1,556,759 
Cost of product revenue   
–
    
–
    96,237    96,237 
Selling, general and administrative expenses   
–
    2,974,130    64,806    3,038,936 
Depreciation and amortization   277,866    5,084    
–
    282,950 
Impairment loss   716,000    
–
    
–
    716,000 
Total Operating Expenses   4,545,752    2,979,214    161,043    7,686,009 
                     
Loss from operations  $(1,673,575)  $(2,946,789)  $(57,284)  $(4,677,648)
                     
Other Segment Information                    
Loss on extinguishment of debt  $
–
   $178,986   $
–
   $178,986 
Change in fair value of debt  $
–
   $(84,109)  $
–
   $(84,109)
Amortization of original issue discounts on notes payable  $5,007   $1,311,158   $
–
   $1,316,165 
Gain from realization of contingent sale consideration receivable  $
–
   $(125,355)  $
–
   $(125,355)
Interest expense and other  $11,506   $156,638   $
–
   $168,144 
                     
Identifiable Assets                    
Identifiable assets as of December 31, 2024  $496,391   $1,719,020   $7,578   $2,222,989 


 The Digital Healthcare made intercompany sales of $-0- and $1,116 in the years ended December 31, 2025 and 2024, respectively, related to subscription revenue billed to and paid for by the Company’s physicians for access to the HealthLynked Network. The Medical Distribution segment made intercompany sales of $-0- and $238 in the years ended December 31, 2025 and 2024, respectively, related to medical products sold to practices in the Company’s Health Services segment. Intercompany revenue and the related costs are eliminated on consolidation. The revenues, significant expense categories and amounts align with the segment-level information that is regularly provided to the Company’s chief operating decision maker (“CODM”), which is the Company’s CEO, Dr. Michael Dent.